ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

ARRA Funding Announcements Listed

April 10, 2009

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

Physician Indicted for Mail Fraud After allegedly Falsifying Data Of Patients On ECOG, CALGB Trials

March 30, 1984